Sanger Institute Spin-Out Microbiotica To Evaluate Bacterial Mixes

The UK Wellcome Trust Sanger Institute’s latest spin-out has received start-up funding to exploit more than six years of gut bacterial genome sequencing in order to develop novel bacteria-based therapies for a range of diseases.